Showing results (601-610 of 718) with videos related to

Sort By:
Pageof 72
The Australasian Journal of Dermatology|December 17, 2020
Neutrophilic dermatosis: a new skin manifestation and novel pathogenic variant in a rare autoinflammatory diseaseMaine Luellah Demaret Bardou, Maria Cecilia Rivitti-Machado, Nilceo Schwery Michalany, et al.
Molecular Psychiatry|September 25, 2013
Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structuresS Liebscher, R M Page, K Käfer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 26, 2025
Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING-Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart TherapySara Alehashemi, Bjoern Buehring, Adriana A de Jesus, et al.
Annals of the Rheumatic Diseases|April 23, 2024
Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAASKader Cetin Gedik, Ana M Ortega-Villa, Grace Materne, et al.
Arthritis Research & Therapy|April 8, 2020
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathiesHanna Kim, Fatima Gunter-Rahman, John A McGrath, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2017
Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic ChallengesJ B Kuemmerle-Deschner, D Verma, T Endres, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 7, 2021
Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1Deborah L Stone, Amanda Ombrello, Juan I Arostegui, et al.
Journal of Clinical Immunology|October 23, 2024
Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I InterferonopathiesGenia Kretzschmar, Laura Piñero Páez, Ziyang Tan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2010
Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigensXi Zhao, Anamika Bose, Hideo Komita, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 20, 2020
Longitudinal determination of resilience in humans to identify mechanisms of resilience to modern-life stressors: the longitudinal resilience assessment (LORA) studyA Chmitorz, R J Neumann, B Kollmann, et al.
Pageof 72